5:17 PM
 | 
Oct 04, 2013
 |  BC Extra  |  Company News

Discovery leaps on Surfaxin launch update

Discovery Laboratories Inc. (NASDAQ:DSCO) gained $0.73 (37%) to $2.70 on Friday after confirming that it plans to launch Surfaxin lucinactant this quarter after FDA...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >